Fig. 8From: Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trialsHRQOL mean score (with 95% Confidence Interval) for IS and FCM therapy for the physical functioning (PF), role limitations due to physical health (PH), role limitations due to emotional problems (EP), Energy/Fatigue (E/F), emotional well-being (EWB), social functioning (SoF), pain, general health (GH) domains at baseline, week 2 and week 4Back to article page